• Careplus Group seeks shareholder approval for a renounceable rights issue at its extraordinary general meeting on November 25, 2026.
• The proposal covers up to 425,394,849 new ordinary shares, offering one rights share for every two existing shares.
• Gross proceeds could reach RM 29.78 million at an illustrative issue price of RM 0.07 per rights share.
• Shareholder undertakings support minimum proceeds of RM 4.38 million; funding priorities include working capital, NEV manufacturing hub construction and dealership expansion.
• The board recommends voting in favor of the proposal.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Careplus Group Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3722633) on November 06, 2026, and is solely responsible for the information contained therein.